Intracameral r-tPA for the management of severe fibrinous reactions in TASS after cataract surgery.
2021
Background:To describe the use of intracameral recombinant tissue plasminogen activator (r-tPA) in the treatment of severe fibrinous reactions in toxic anterior segment syndrome (TASS) after catara...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
22
References
1
Citations
NaN
KQI